As of 2025-06-20, the Relative Valuation of Kura Oncology Inc (KURA) is (43.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.06 USD, the upside of Kura Oncology Inc based on Relative Valuation is -822.9%.
The range of the Relative Valuation is (26.89) - (55.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 26.2x | 19.4x |
| Forward P/E multiples | 12.8x - 31.8x | 22.3x |
| Fair Price | (26.89) - (55.05) | (43.81) |
| Upside | -543.8% - -1008.4% | -822.9% |
| Date | P/E |
| 2025-06-18 | -2.88 |
| 2025-06-17 | -2.95 |
| 2025-06-16 | -3.09 |
| 2025-06-13 | -3.07 |
| 2025-06-12 | -3.17 |
| 2025-06-11 | -3.29 |
| 2025-06-10 | -3.24 |
| 2025-06-09 | -3.20 |
| 2025-06-06 | -3.20 |
| 2025-06-05 | -3.13 |
| 2025-06-04 | -3.07 |
| 2025-06-03 | -3.06 |
| 2025-06-02 | -3.00 |
| 2025-05-30 | -2.71 |
| 2025-05-29 | -2.77 |
| 2025-05-28 | -2.64 |
| 2025-05-27 | -2.67 |
| 2025-05-23 | -2.68 |
| 2025-05-22 | -2.97 |
| 2025-05-21 | -2.95 |
| 2025-05-20 | -3.04 |
| 2025-05-19 | -2.97 |
| 2025-05-16 | -2.87 |
| 2025-05-15 | -2.83 |
| 2025-05-14 | -2.73 |
| 2025-05-13 | -2.76 |
| 2025-05-12 | -2.90 |
| 2025-05-09 | -2.74 |
| 2025-05-08 | -2.86 |
| 2025-05-07 | -2.69 |
| 2025-05-06 | -2.76 |
| 2025-05-05 | -3.20 |
| 2025-05-02 | -3.08 |
| 2025-05-01 | -3.09 |
| 2025-04-30 | -3.12 |
| 2025-04-29 | -3.10 |
| 2025-04-28 | -3.10 |
| 2025-04-25 | -3.06 |
| 2025-04-24 | -3.06 |
| 2025-04-23 | -3.03 |
| 2025-04-22 | -3.00 |
| 2025-04-21 | -2.94 |
| 2025-04-17 | -2.81 |
| 2025-04-16 | -2.74 |
| 2025-04-15 | -2.87 |
| 2025-04-14 | -2.78 |
| 2025-04-11 | -2.75 |
| 2025-04-10 | -2.68 |
| 2025-04-09 | -2.84 |
| 2025-04-08 | -2.67 |